Abstract:Recent work suggests that extracellular (cell-free) nucleic acids, both DNA and RNA species, as well as extracellular nucleosomes can activate blood coagulation and promote thrombosis in vitro and in vivo (1, 2). Indeed, they substantially contribute to the development of microvascular thrombosis which can act as an intravascular immune response to circulating bacteria and has been termed immunothrombosis (3). However, they also foster pathological vessel occlusions as shown in animal models of large vessel thrombosis including deep-vein thrombosis and arterial thrombosis. Large filaments of extracellular nucleosomes that are released from activated neutrophils (neutrophil extracellular traps, NETs) and isolated extracellular nucleosomes support fibrin formation and platelet adhesion/activation via different mechanisms. These include for example stimulation of fibrin formation by degradation of the endogenous anticoagulant tissue factor pathway inhibitor and via activation of proteins involved in the contact pathway of blood coagulation such as factor XII (2, 3). The study by Varju et al. (4) adds a new aspect to the procoagulant role of nucleosome components and NETs. These authors show that isolated eukaryotic DNA and histone proteins such as HIIIS enhance the diameter of thrombus-forming fibrin fibers under in vitro conditions. Moreover, they are found to decrease the permeability of fibrin clots and to enhance the overall stability of such clots. Mechanistically, these effects are mediated by regulation of endogenous anticoagulant and fibrinolytic pathways. Indeed, histone proteins prevented the inactivation of thrombin by antithrombin and DNA reduced plasminogen activation. Furthermore, NETs released from isolated neutrophils suppressed t-PA-promoted fibrinolysis. Together with earlier work, these results further corroborate the conclusion that extracellular nucleosomes and their major components target the coagulation system at different levels and that their overall effect is to enhance fibrin formation. It will be of interest to clarify in the future whether the stabilization of fibrin clots by histones, DNA and nucleosomes as shown in (4) contributes to the prothrombotic role of NETs and extracellular nucleosomes in vivo.

Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA

Gene expression of fibrinolytic markers in coronary thrombi

Neutrophil extracellular traps formation and deposition of fibrin and von Willebrand factor during human coronary atherogenesis

Characterization of Biomarkers of Thrombo-Inflammation in Patients with First-Diagnosed Atrial Fibrillation

Histone content, and thus DNA content, is associated with differential in vitro lysis of acute ischemic stroke clots

Relationship between thrombus vWF and NETs with clinical severity and peripheral blood immunocytes' indicators in patients with acute ischemic stroke

Extracellular DNA and histones as thrombus stabiliser

Von Willebrand Factor Collagen-Binding Activity and Von Willebrand Factor-Mediated Platelet Adhesion in Patients with Coronary Artery Disease

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting

Thromboinflammation is associated with clinical outcome after ST-elevation myocardial infarction

Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS

Extracellular DNA and histones: double‐edged swords in immunothrombosis

Elevated Plasma Von Willebrand Factor Antigen and Activity Levels Are Associated with the Severity of Coronary Stenosis.

Vascular Endothelial Dysfunction and Immunothrombosis in the Pathogenesis of Atrial Fibrillation

Abstract WP152: Changes In Thrombus Fibrin Content By Time In Patients Undergoing Thrombectomy

Circulating levels of neutrophil extracellular traps reflects local neutrophil activity but not fibrinolytic activity in coronary thrombi from patients with ST-elevation myocardial infarction

Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation

Assessment of associations between neutrophil extracellular trap biomarkers in blood and thrombi in acute ischemic stroke patients

Alterations of Hemostatic Molecular Markers During Acute Large Vessel Occlusion Stroke

Correlation of von Willebrand factor and platelets with acute ischemic stroke etiology and revascularization outcome: an immunohistochemical study

Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution